ClinicalTrials.gov
public full text
Public Domain
The Role of N-acetyl-l-cysteine (NAC) as an Adjuvant to Opioid Treatment in Patients With Chronic Neuropathic Pain
This study will test whether treatment with N-acetyl-L-cysteine (NAC) is safe and decreases pain in patients with chronic neuropathic pain. The investigators hypothesize that NAC will be a useful adjunct to opioid treatment in chronic neuropathic pain.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- N-acetyl Cysteine Effect in Peripheral Neuropathy in Cancer Patients#1088577
- Cost-utility and Physiological Effects of LDN in Patients With Fibromyalgia#1195519
- Comparing Gabapentin and Amitriptyline for the Treatment of Neuropathic Pain in Children and Adolescents#1231676
- N-Acetyl Cysteine Supplementation in Therapy Refractory Major Depressive Disorders#846994
- Analgesic Effect of Beta 2-mimetics in the Treatment of Neuropathic Pain#1103225
Record · ID 1352806
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive